Literature DB >> 16524693

Burkholderia pseudomallei RpoS regulates multinucleated giant cell formation and inducible nitric oxide synthase expression in mouse macrophage cell line (RAW 264.7).

P Utaisincharoen1, S Arjcharoen, K Limposuwan, S Tungpradabkul, S Sirisinha.   

Abstract

Burkholderia pseudomallei is the causative agent of melioidosis. This bacterium can invade and survive inside the phagocytic and nonphagocytic cells. After internalization, the bacteria can escape from the membrane-bound phagosome into the cytoplasm. Internalised B. pseudomallei can also induce a cell-to-cell fusion, resulting in a multinucleated giant cell (MNGC) formation. In the present study, we demonstrated that B. pseudomallei rpoS null mutant was similar to its wild type parent in its ability to survive and multiply inside the mouse macrophages, but it failed to stimulate MNGC formation. The rpoS mutant was also unable to activate inducible Nitric Oxide Synthase (iNOS) in resting mouse macrophages but in gamma interferon (IFN-gamma)-activated macrophages, the mutant was able to induce significantly higher levels of iNOS and NO when compared with its wild-type counterpart, resulting in a significantly lower number of bacteria inside the infected host cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16524693     DOI: 10.1016/j.micpath.2006.01.002

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  20 in total

1.  Burkholderia pseudomallei type III secretion system mutants exhibit delayed vacuolar escape phenotypes in RAW 264.7 murine macrophages.

Authors:  Mary N Burtnick; Paul J Brett; Vinod Nair; Jonathan M Warawa; Donald E Woods; Frank C Gherardini
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

Review 2.  Role of RpoS in virulence of pathogens.

Authors:  Tao Dong; Herb E Schellhorn
Journal:  Infect Immun       Date:  2009-11-30       Impact factor: 3.441

3.  Burkholderia mallei cluster 1 type VI secretion mutants exhibit growth and actin polymerization defects in RAW 264.7 murine macrophages.

Authors:  Mary N Burtnick; David DeShazer; Vinod Nair; Frank C Gherardini; Paul J Brett
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

Review 4.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

5.  Burkholderia pseudomallei-induced expression of a negative regulator, sterile-alpha and Armadillo motif-containing protein, in mouse macrophages: a possible mechanism for suppression of the MyD88-independent pathway.

Authors:  M Pudla; K Limposuwan; P Utaisincharoen
Journal:  Infect Immun       Date:  2011-05-09       Impact factor: 3.441

Review 6.  Melioidosis: molecular aspects of pathogenesis.

Authors:  Joshua K Stone; David DeShazer; Paul J Brett; Mary N Burtnick
Journal:  Expert Rev Anti Infect Ther       Date:  2014-10-14       Impact factor: 5.091

7.  Transcription level analysis of intracellular Burkholderia pseudomallei illustrates the role of BPSL1502 during bacterial interaction with human lung epithelial cells.

Authors:  Teerasit Techawiwattanaboon; Tanachaporn Bartpho; Rasana Wongratanacheewin Sermswan; Sorujsiri Chareonsudjai
Journal:  J Microbiol       Date:  2015-01-28       Impact factor: 3.422

8.  Nitric oxide-dependent killing of aerobic, anaerobic and persistent Burkholderia pseudomallei.

Authors:  Jessica Jones-Carson; James R Laughlin; Amanda L Stewart; Martin I Voskuil; Andrés Vázquez-Torres
Journal:  Nitric Oxide       Date:  2012-04-10       Impact factor: 4.427

9.  Protection from pneumonic infection with burkholderia species by inhalational immunotherapy.

Authors:  Andrew Goodyear; Lisa Kellihan; Helle Bielefeldt-Ohmann; Ryan Troyer; Katie Propst; Steven Dow
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

Review 10.  Melioidosis.

Authors:  W Joost Wiersinga; Harjeet S Virk; Alfredo G Torres; Bart J Currie; Sharon J Peacock; David A B Dance; Direk Limmathurotsakul
Journal:  Nat Rev Dis Primers       Date:  2018-02-01       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.